South Korean Investors Structuring $305 Million Acquisition of Novo Nordisk

Representation of a consortium of South Korean investors in connection with structuring its $305 million acquisition of Novo Nordisk’s 762,000-square-foot North American headquarters in Plainsboro, New Jersey, marking the largest single-asset sales in New Jersey in 2016.